Trials / Recruiting
RecruitingNCT04903912
Campania Registry On Peripheral Artery Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The CAmpania REgistry on Peripheral Artery Disease (CARE-PAD) is a single-center observational study which has the purpose to collect clinical, laboratory, instrumental, procedural and follow-up data and to evaluate the outcome of peripheral artery disease (PAD) patients.
Detailed description
PAD patients had widespread atherosclerosis and show a worse prognosis than patients with coronary artery disease alone. The CAmpania REgistry on Peripheral Artery Disease (CARE-PAD) is a single center observational study conducted at the Department of Advanced Biomedical Sciences of the Federico II University of Naples which aims to collect clinical, laboratory, instrumental, procedural and follow-up data and to evaluate short, medium and long term outcome of PAD patients. Patients with established diagnosis of peripheral arterial disease according to current international guidelines will be included in the observational study. The overall duration of the study will be 10 years. The presence of PAD will be confirmed based on clinical and instrumental criteria: * Intermittent claudication and/or critical limb ischemia with presence of haemodynamically significant stenosis/occlusion of the lower limb arteries detected by ultrasound and/or other imaging methods or with ankle/brachial index (ABI) ≤ 0.90. * Carotid stenosis of at least 50% at ultrasound and/or at other imaging methods * Abdominal aortic aneurysm (≥3 cm) found at ultrasound and/or other imaging methods. * History of peripheral/carotid revascularization or of aortic aneurysm treatment. All patients will be managed according to current guidelines and will receive maximal antiatherosclerotic medical therapy to improve cardiovascular prognosis and, if clinically indicated, could undergo peripheral revascularization procedures to improve symptoms and/or limb prognosis. The choice of the revascularization procedure will be based on careful individual evaluation and will take into account, in accordance with current guidelines, several variables such as clinical characteristics, comorbidities, individual surgical risk and feasibility of the percutaneous peripheral revascularization procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Vascular ultrasound or other imaging methods according to current guidelines | Peripheral vascular ultrasound / ankle/brachial index / CT angiography / MR angiography / angiography |
| DIAGNOSTIC_TEST | Laboratory tests | Metabolic profile and platelet reactivity |
| DRUG | Medical treatment according to current guidelines | Antithrombotic drugs, lipid-lowering drugs, antihypertensive drugs, and pharmacotherapy to increase walking capacity according to current guidelines |
| PROCEDURE | Endovascular od surgical peripheral revascularizations | Endovascular od surgical peripheral revascularizations according to current guidelines |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2031-05-01
- Completion
- 2031-05-01
- First posted
- 2021-05-27
- Last updated
- 2021-05-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04903912. Inclusion in this directory is not an endorsement.